These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17150005)

  • 21. [Microalbuminuria: cardiovascular and renal risk factors underestimated in clinical practice].
    Zanella MT
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):313-21. PubMed ID: 16767297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-Analysis of the Effect of Dietary Sodium Restriction with or without Concomitant Renin-Angiotensin-Aldosterone System-Inhibiting Treatment on Albuminuria.
    D'Elia L; Rossi G; Schiano di Cola M; Savino I; Galletti F; Strazzullo P
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1542-52. PubMed ID: 26240299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
    Li XC; Zhang J; Zhuo JL
    Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.
    van de Wal RM; Gansevoort RT; van der Harst P; Boomsma F; Thijs Plokker HW; van Veldhuisen DJ; de Jong PE; van Gilst WH; Voors AA
    Hypertension; 2006 Nov; 48(5):870-6. PubMed ID: 17000930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.
    Mercier K; Smith H; Biederman J
    Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microalbuminuria and urinary albumin excretion: French guidelines].
    Halimi JM; Hadjadj S; Aboyans V; Allaert FA; Artigou JY; Beaufils M; Berrut G; Fauvel JP; Gin H; Nitenberg A; Renversez JC; Rusch E; Valensi P; Cordonnier D;
    Ann Biol Clin (Paris); 2008; 66(3):277-84. PubMed ID: 18558566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimal nephroprotection: use, misuse and misconceptions about blockade of the renin-angiotensin system. Lessons from the ONTARGET and other recent trials.
    Halimi JM; Asmar R; Ribstein J
    Diabetes Metab; 2009 Dec; 35(6):425-30. PubMed ID: 19786360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of renin angiotensin system inhibitors in cardiovascular and renal protection: a lesson from clinical trials.
    Stojiljkovic L; Behnia R
    Curr Pharm Des; 2007; 13(13):1335-45. PubMed ID: 17506719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial.
    Bakris GL; Ruilope L; Locatelli F; Ptaszynska A; Pieske B; de Champlain J; Weber MA; Raz I
    Kidney Int; 2007 Oct; 72(7):879-85. PubMed ID: 17667984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On target to dual block RAS?
    Papadopoulos DP; Papademetriou V; Makris TK
    Angiology; 2009 Dec-2010 Jan; 60(6):739-49. PubMed ID: 19144653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
    Rosano GMC; Tamargo J; Kjeldsen KP; Lainscak M; Agewall S; Anker SD; Ceconi C; Coats AJS; Drexel H; Filippatos G; Kaski JC; Lund L; Niessner A; Ponikowski P; Savarese G; Schmidt TA; Seferovic P; Wassmann S; Walther T; Lewis BS
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):180-188. PubMed ID: 29726985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of the renin-angiotensin-aldosterone system: a key therapeutic strategy to reduce renal and cardiovascular events in patients with diabetes.
    Burnier M; Zanchi A
    J Hypertens; 2006 Jan; 24(1):11-25. PubMed ID: 16331093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
    Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
    Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-angiotensin system blockade and reduction of cardiovascular risk: future perspectives.
    de la Sierra A
    Expert Rev Cardiovasc Ther; 2011 Dec; 9(12):1585-91. PubMed ID: 22103877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased urinary protein excretion in the "normal" range is associated with increased renin-angiotensin system activity.
    Nicholl DD; Hemmelgarn BR; Turin TC; MacRae JM; Muruve DA; Sola DY; Ahmed SB
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F526-32. PubMed ID: 22088437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-grade albuminuria and cardiovascular risk : what is the evidence?
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Paar WD; Bramlage P; Pittrow D; Böhm M
    Clin Res Cardiol; 2007 May; 96(5):247-57. PubMed ID: 17453140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of microalbuminuria in achieving blood pressure goals.
    Duka I; Bakris G
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
    Jin SM; Han KA; Yu JM; Sohn TS; Choi SH; Chung CH; Park IeB; Rhee EJ; Baik SH; Park TS; Lee IK; Ko SH; Hwang YC; Cha BS; Lee HW; Nam MS; Lee MK
    Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2108-14. PubMed ID: 27493100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.